Products and Resources Catalog

In recent years, there has been growing support for a harm reduction approach to drug policy, which emphasizes reducing some of the negative consequences associated with drug use through a variety of public health measures. Historically, this approach has been a core value of syringe service programs, expanding into other settings particularly as rising overdose deaths have made educating people about overdose risks and distributing naloxone more urgent. This two-part workshop will explore how harm reduction is evolving, different interpretations of what harm reduction is (or isn’t), and ways to build bridges between harm reduction services and the continuum of care for people who use drugs. Discussion topics will include how harm reduction providers are offering or connecting participants to various types of treatment, broadly defined, and how treatment providers are incorporating harm reduction strategies into their services.

Peer professionals provide an array of recovery-oriented supports and person-centered care which include empathetic engagement with survivors of trauma circumstances. This work at times can increase the peer’s vulnerability to vicarious trauma or secondary stress. Potentially it can result in the loss of ability to objectively help others find their recovery pathways and can affect the peer’s mental and emotional wellbeing. This two-hour interactive workshop will review how trauma situations may present, signs to recognize and cues alerting as to when to step away from a trauma inducing situation. Content will also offer practical strategies for self-care including ways to build resiliency.

The mental and emotional well-being of diverse populations are exacerbated by social, environmental, and economic conditions that have been identified as barriers affecting help seeking behaviors. Moreover, research is indicating how organizational staff providing services to diverse communities are increasingly experiencing their own wellness challenges dealing with client loss and overwhelming responsibilities, and can benefit from work environments that consider and support their wellbeing.  The National Culturally and Linguistically Appropriate Services (CLAS) Standards provide a framework to assist organizations to work more effectively and resourcefully with diverse populations. This interactive training will instruct on how to implement the National CLAS Standards within behavioral health care settings to build organizational capacity and provide culturally informed and linguistically conducive services that enhance recovery and wellness pathways, integrate strategies to reduce racial and ethnic disparities, and advance behavioral health equity and inclusion for both communities and the professionals that provide care.

The use of electronic vaporizing devices (“vaping”) has skyrocketed in popularity since their widespread introduction across the United States. Through these devices, consumers inhale an aerosolized liquid compound, most commonly liquid nicotine or cannabis-derived chemicals (both CBD and THC). Risks stemming from vaping present an important public health challenge, particularly for youth, but also among adults. While significant research gaps remain, a growing number of evidence-based practices are available to behavioral health practitioners.  

This live interactive training through professional development plan assignments, combined with “Clinical Supervision Foundations I” training, met the 30-hour Clinical Supervision training requirement for the Advanced Counselor and Master Counselor status, as referenced in the OASAS Substance Use Disorder Scope of Practice. This training recognizes the crucial role that Clinical Supervision holds as the cornerstone of performance improvement at both the program and client level. Clinical Supervision, when properly implemented by competent Clinical Supervisors, improves client care, develops clinical skills, and improves the knowledge and professionalism of clinical personnel. It is also paramount in imparting and maintaining ethical standards in the addiction profession.

This live interactive training through professional development plan assignments, combined with “Clinical Supervision Foundations I” training, met the 30-hour Clinical Supervision training requirement for the Advanced Counselor and Master Counselor status, as referenced in the OASAS Substance Use Disorder Scope of Practice. This training recognizes the crucial role that Clinical Supervision holds as the cornerstone of performance improvement at both the program and client level. Clinical Supervision, when properly implemented by competent Clinical Supervisors, improves client care, develops clinical skills, and improves the knowledge and professionalism of clinical personnel. It is also paramount in imparting and maintaining ethical standards in the addiction profession.

This live interactive training through professional development plan assignments, combined with “Clinical Supervision Foundations I” training, met the 30-hour Clinical Supervision training requirement for the Advanced Counselor and Master Counselor status, as referenced in the OASAS Substance Use Disorder Scope of Practice. This training recognizes the crucial role that Clinical Supervision holds as the cornerstone of performance improvement at both the program and client level. Clinical Supervision, when properly implemented by competent Clinical Supervisors, improves client care, develops clinical skills, and improves the knowledge and professionalism of clinical personnel. It is also paramount in imparting and maintaining ethical standards in the addiction profession.

The New England ATTC in partnership with the New England Association of Recovery Court Professionals recently hosted a webinar titled, "Data-Based Insights on Cannabis Use Disorder Treatment, Recovery, and Implications for Recovery Courts" Dr. Michael J. Sofis reviewed recent findings from the Cannabis Public Policy Consulting’s Regulatory Determinants of Cannabis Outcomes Survey (RDCOS) from 25 adult use, medical-only, and illegal/low-THC states on the prevalence of cannabis use harms like cannabis use disorder (CUD), driving under the influence of cannabis. (DUIC), and youth cannabis use. He highlighted promising up-and-coming treatment and prevention approaches designed to help prevent cannabis harms and contextualize how such approaches will impact recovery courts.  View the recording from the Data-Based Insights on Cannabis Use Disorder Treatment and Recovery Implications for Recovery Courts by clicking on the view resource button above. 

The New England ATTC in partnership with the New England Association of Recovery Court Professionals recently hosted a webinar titled, "Data-Based Insights on Cannabis Use Disorder Treatment, Recovery, and Implications for Recovery Courts" Dr. Michael J. Sofis reviewed recent findings from the Cannabis Public Policy Consulting’s Regulatory Determinants of Cannabis Outcomes Survey (RDCOS) from 25 adult use, medical-only, and illegal/low-THC states on the prevalence of cannabis use harms like cannabis use disorder (CUD), driving under the influence of cannabis. (DUIC), and youth cannabis use. He highlighted promising up-and-coming treatment and prevention approaches designed to help prevent cannabis harms and contextualize how such approaches will impact recovery courts.  View the slides from the Data-Based Insights on Cannabis Use Disorder Treatment and Recovery Implications for Recovery Courts by clicking on the view resource button above. 

In recent years, there has been growing support for a harm reduction approach to drug policy, which emphasizes reducing some of the negative consequences associated with drug use through a variety of public health measures. Historically, this approach has been a core value of syringe service programs, expanding into other settings particularly as rising overdose deaths have made educating people about overdose risks and distributing naloxone more urgent. This two-part workshop will explore how harm reduction is evolving, different interpretations of what harm reduction is (or isn’t), and ways to build bridges between harm reduction services and the continuum of care for people who use drugs. Discussion topics will include how harm reduction providers are offering or connecting participants to various types of treatment, broadly defined, and how treatment providers are incorporating harm reduction strategies into their services.

In recent years, there has been growing support for a harm reduction approach to drug policy, which emphasizes reducing some of the negative consequences associated with drug use through a variety of public health measures. Historically, this approach has been a core value of syringe service programs, expanding into other settings particularly as rising overdose deaths have made educating people about overdose risks and distributing naloxone more urgent. This two-part workshop will explore how harm reduction is evolving, different interpretations of what harm reduction is (or isn’t), and ways to build bridges between harm reduction services and the continuum of care for people who use drugs. Discussion topics will include how harm reduction providers are offering or connecting participants to various types of treatment, broadly defined, and how treatment providers are incorporating harm reduction strategies into their services.

Presenter: Lisa A. Marsch, PhD (Dartmouth Center for Technology and Behavioral Health) Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings. In this presentation, Dr. Lisa A. Marsch (Dartmouth Center for Technology and Behavioral Health) will review the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world. Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network.  Download slides | Watch recording

Presenters: Ashton Marra and Jonathan Stoltman, Co-Directors of ReportingOnAddiction.org January 2023 Mainstream media perpetuates many problematic narratives about drug use and addiction that increase stigma, discrimination, and bad policy. One way to address these shortcomings is to increase the coverage of evidence-based approaches to addiction treatment and recovery. To do this, we need bridges between subject matter experts and the media. However, many experts are not trained to interact with journalists in today’s media environment. Thus, this workshop is designed to offer customized training to support interactions between the addiction workforce and the media. Topics covered include preparing for interviews and how to pitch ideas/op-eds to the media. Download slides | Watch recording

Talking To Change: A Motivational Interviewing Podcast, hosted by Glenn Hinds and Sebastian Kaplan, is a series of conversations exploring Motivational Interviewing (MI) and its influence on supporting individuals and groups as they make positive health and lifestyle changes. Talking to Change: An MI Podcast. Talking to Change: An MI Podcast. Episode 60: Training MI Across Cultures, with Rik Bes. In this episode, Glenn and Sebastian welcomed Rik Bes to the podcast to discuss his work training MI across cultures. Rik talks about how to bring client-centeredness to addiction services in The Netherlands, ways to broaden the cultural scope, adaptations and metaphors from the Middle East to New Zealand, the importance of co-training and seeking feedback, and how to develop hybrid training programs.  

About this series: The Great Lakes ATTC and MHTTC are excited to offer these introductory training videos on the use of SBIRT (Screening, Brief Intervention, Referral to Treatment). This series includes three simulated patient recordings with each portraying a realistic scenario focusing on one part of the SBIRT screening process (brief intervention, initiating brief treatment, referral to treatment).   The Great Lakes ATTC and MHTTC also offer live virtual trainings on SBIRT and Motivational Interviewing (MI). These trainings take place on a recurring basis throughout the year, and they are perfect for those who are new to MI and SBIRT, as well as practitioners who are interested in refreshing their knowledge and skills in an interactive virtual learning environment. Check out our 2023 Motivational Interviewing and SBIRT Training Schedule landing page for more information and to register!     Watch the Introduction to Screening, Brief Intervention, Referral to Treatment (SBIRT) Training Video. (57 min.)     Watch the Introduction to SBIRT for FQHCs Training Video. (18 min.) This video presents supplementary introductory information specific to FQHCs. It is recommended everyone watch the full intro video first.      Watch the SBIRT: A Brief Intervention for Alcohol & Cannabis Use Simulated Patient Training. (15 min.)     Watch the SBIRT: Initiating Brief Treatment for Substance Use Disorder (SUD) Simulated Patient Training Video. (18 min.)     Watch the SBIRT: Referral to Treatment Simulated Patient Training Video. (18 min.)     Don't forget to subscribe to the official YouTube channel of the Great Lakes ATTC, MHTTC, and PTTC, The Great Lakes Current! We upload brand new content and resources every week that help support the SUD, behavioral health, mental health, and prevention workforces of our region. Be sure to subscribe and turn on notifications so that you can be the first to access new content as soon as it's available!  

The second session of Ethics in a Rural Context: Application & Case Studies will be directly relevant to licensed professionals, with a focus on boundaries of competence.    

Throughout the month of September 2022, the Idaho Department of Health & Welfare in partnership with Recovery Idaho, Idaho Harm Reduction Project, and the Northwest ATTC hosted a series of online webinars titled “Recovery is Health, Health is Recovery." During the series, presenters discussed a range of topics relating to transmissible disease, treatment and precautionary measures, as well as harm reduction practices. Part 6: September 22, 2022 Presenter: Evan Burke, Idaho Harm Reduction Project In this session, Evan Burke provided an overview of harm reduction informed practices that can be incorporated into an individual’s drug use to reduce their risk of overdose. Read more about this session and its presenter. Watch the recording | Download slides

  Mid-America ATTC  (MATTC) partnered with the Ethnic Communities Opioid Response Network in Missouri, the Addiction Policy Forum, and the Opioid Response Network (ORN in IA, KS, MO, and NE) to translate Prevention of Opioid Use Education Materials into ten different languages and ensure they are culturally appropriate.

The Mountain Plains ATTC has created a new Health-e-Knowledge course, Older Adults and Substance Use, this course provides an overview of aging and the issues associated with the use of substance by older adults. It highlights some of the contributing factors to this increase of substance use in older adults and provides some initial approaches that can assist primary care and behavioral health providers in assessing the use of substances and possible interventions. Also, modifications that may need to be considered when assessing and intervening with older adults around substance use is provided. Course can be found on the Health-e-Knowledge Website.    

The New England Addiction Technology Transfer Center (ATTC), and the New England Association of Recovery Court Professionals (NEARCP), recently hosted a new webinar for criminal justice professionals. This program focused on the gender-based predictors of and patterns and pathways into substance misuse and the criminal justice system and addressed the specific treatment, trauma, relationship, familial responsibility, physical and mental health, and economic circumstances of women that must be appropriately addressed during drug court participation. The program concluded with the processes, personnel, and programs necessary to build a successful gender-specific specialized docket. View the recording from the Honoring Women: A Model for Gender-Specific Specialized Dockets by clicking on the view resource button above. More information about the event can be found here. 

TIC What’s in Your Soil: The Power of Community Join us for a heart-felt, wide-ranging discussion with our guest, Kim Shaw-Ellis, and get inspired by the power of being seen, valued, and connected, the power of intentional focus on goodness andways we get that which we seek, and the power of collaborating to solve problems that impact our communities and each other in ways that transform pain into joy and healing.

La falta de aceptación puede interferir con los atentos de ampliar el uso de tratamientos asistidos por medicamentos (TAM) para los trastornos por consumo de sustancias (TCS). Las Hojas Informativas de TAM ofrecen estrategias para generar apoyo para esta práctica basada en evidencia.  Hoja Informativa #1: Asegurando la Aceptación              Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación              Hoja Informativa #3: Abogando por las Medicamentos 

Lack of buy-in can interfere with attempts to expand use of medication-assisted treatment (MAT) for substance use disorders. These three fact sheets offer strategies to build support for this evidence-based practice.  MAT Fact Sheet #1: Securing Buy-in            MAT Fact Sheet #2: Reducing Risk of Misuse and Diversion          MAT Fact Sheet #3: Making the Case for Medication

The Great Lakes ATTC, MHTTC, and PTTC have created an online flipbook for the Alcohol is STILL a Drug series. Alcohol is STILL a Drug is comprised of ten 30-minute videos recorded between September 2021–August 2022. Each video addresses the impacts of alcohol use disorder (AUD) and is presented by a leading professional in that field.    You can view the flipbook online or you can download a PDF version. The videos and supplemental resources are accessible in either format.      ABOUT THE SERIES: The opioid crisis, increasing stimulant misuse, and marijuana legalization often dominate the news—yet alcohol remains the number one substance negatively impacting physical health, mental health, social engagement, and financial stability for individuals throughout the US.   While this series will focus on the hopefulness of recovery from AUD, it will also take a deep dive into what we know about the full impact of alcohol overuse and the ways it affects everyone, even those who do not personally misuse alcohol.   The Alcohol Is Still a Drug series offers viewers the following learning objectives: Summarize the current impacts of problematic alcohol use in various/special populations, including pregnant women, youth, rural, and minority populations Assess and prioritize alcohol reduction efforts in targeted settings Describe the current efforts to curb problematic alcohol use, including best practices in providing treatment Understand the importance of person-centered approaches to treatment and recovery